Effect of barbital on carcinogenic action and metabolism of 4-dimethylaminoazobenzene.
D062365:Aminobenzoates / Q000032:analysis; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology*; D001646:Bile / Q000032:analysis / Q000378:metabolism; D005965:Glucuronates / Q000032:analysis; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology*; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000378:metabolism*; D010088:Oxidoreductases / Q000032:analysis; D051381:Rats; D013431:Sulfates / Q000032:analysis; D004124:p-Dimethylaminoazobenzene / Q000378:metabolism*
D062365:Aminobenzoates; D001463:Barbiturates; D005965:Glucuronates; D013431:Sulfates; D008748:Methylcholanthrene; D004124:p-Dimethylaminoazobenzene; D010088:Oxidoreductases